Results 301 to 310 of about 43,593 (360)
Therapeutic Targets in Advanced Penile Cancer: From Bench to Bedside. [PDF]
Pagliaro LC+3 more
europepmc +1 more source
Objectives To provide the first comprehensive molecular characterisation of penile intraepithelial neoplasia (PeIN) and to define the molecular alterations and clinical parameters associated with recurrence in order to enhance our ability to manage this disease.
Sara Kaczor Elbæk+6 more
wiley +1 more source
New histological risk grading system for prediction of lymph node metastasis in patients with penile cancer. [PDF]
Dorofte L+4 more
europepmc +1 more source
Penile cancer information on the internet: a needle in a haystack
Jiasian Teh+7 more
openalex +1 more source
ABSTRACT Background People with intellectual disability have higher rates of cancer mortality than the general population. Cancer prevention programmes and screenings are recommended in adults, including those with intellectual disability. The opinions of relevant parties are important to ensure that people with intellectual disability can achieve ...
Martin McMahon+8 more
wiley +1 more source
Risk factors for distant metastasis and prognosis of the penile cancer with distant metastasis. [PDF]
Zhu Z+10 more
europepmc +1 more source
The dark sides of the GPCR tree ‐ research progress on understudied GPCRs
Abstract A large portion of the human GPCRome is still in the dark and understudied, consisting even of entire subfamilies of GPCRs such as odorant receptors, class A and C orphans, adhesion GPCRs, Frizzleds and taste receptors. However, it is undeniable that these GPCRs bring an untapped therapeutic potential that should be explored further.
Magdalena M. Scharf+10 more
wiley +1 more source
Background and Purpose Myeloid‐derived suppressor cells (MDSCs) play important roles in the pathogenesis of asthma. Recent studies demonstrate that their function can be modulated by different pharmacological approaches. In this study, we focussed on the effects of systemically administered prostaglandin EP4 receptor agonist L‐902,688 and pegylated ...
Tim Lange+7 more
wiley +1 more source